LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China

Brain Research

Volumn 1296, Issue , 2009, Pages 113-116

  Yu, Lihua ^a   Hu, Fayun ^a   Zou, Xiaoyi ^a   Jiang, Yi ^a   Liu, Yan ^b   He, Xianghua ^a   Xi, Jing ^a   Liu, Ling ^a   Liu, Zhuolin ^c   He, Li ^a   Xu, Yanming ^a  

^a SICHUAN UNIVERSITY   (China)

^b Third Hospital of Chengdu   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Case control study; LRRK2 R1628P; Parkinson's disease; Single nucleotide polymorphism

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; CASE-CONTROL STUDIES; CHINA; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES;

EID: 70349267492     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.08.047     Document Type: Article

References (18)

1. An X.K., Peng R., Li T., Burgunder J.M., Wu Y., Chen W.J., Zhang J.H., Wang Y.C., Xu Y.M., Gou Y.R., Yuan G.G., and Zhang Z.J. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Eur. J. Neurol. 15 (2008) 301-305
2. Choi J.M., Woo M.S., Ma H.I., Kang S.Y., Sung Y.H., Yong S.W., Chung S.J., Kim J.S., Shin H.W., Lvoo C.H., Lee P.H., Baik J.S., Kim S.J., Park M.Y., Sohn Y.H., Kim J.H., Kim J.W., Lee M.S., Lee M.C., Kim D.H., and Kim Y.J. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9 (2008) 263-269
3. Cole P., and Macmahon B. Attributable risk percent in case-control studies. Br. J. Prev. Soc. Med. 25 (1971) 242-244
4. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., Fratiglioni L., Lobo A., Martinez-Lage J., Trenkwalder C., and Hofman A. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 Suppl (2000) S21-S23
5. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 991 (2003) 1-14
6. Funayama M., Li Y., Tomiyama H., Yoshino H., Imamichi Y., Yamamoto M., Murata M., Toda T., Mizuno Y., and Hattori N. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 18 (2007) 273-275
7. Gosal D., Ross O.A., and Toft M. Parkinson's disease: the genetics of a heterogeneous disorder. Eur. J. Neurol. 13 (2006) 616-627
8. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
9. Lesage S., Leutenegger A.L., Ibanez P., Janin S., Lohmann E., Dürr A., and Brice A. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am. J. Hum. Genet. 77 (2005) 330-332
10. Lu C.S., Wu-Chou Y.H., van Doeselaar M., Simons E.J., Chang H.C., Breedveld G.J., Di Fonzo A., Chen R.S., Weng Y.H., Lai S.C., Oostra B.A., and Bonifati V. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 9 (2008) 271-276
11. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., and Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354 (2006) 424-425
12. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
13. Rocca W.A. Prevalence of Parkonson's disease in China. Lancet Neurol. 4 (2005) 328-329
14. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., Mata I.F., Lee-Chen G.J., Chen C.M., Tang M., Zhao Y., Hattori N., Farrer M.J., Tan E.K., and Wu R.M. Analysis of LRRK2 R1628P as a risk factor for Parkinson's disease. Ann. Neurol. 64 (2008) 88-92
15. Shults C.W. Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 1661-1668
16. Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., Fook-Chong S., Tang S., Chua E., Yuen Y., Tan L., Pavanni R., Wong M.C., Kolatkar P., Lu C.S., Bonifati V., and Liu J.J. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum. Genet. 120 (2007) 857-863
17. Tan E.K., Tan L.C., Lim H.Q., Li R., Tang M., Yih Y., Pavanni R., Prakash K.M., Fook-Chong S., and Zhao Y. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum. Genet. 124 (2008) 287-288
18. Zimprich A., Müller-Myhsok B., Farrer M., Leitner P., Sharma M., Hulihan M., Lockhart P., Strongosky A., Kachergus J., Calne D.B., Stoessl J., Uitti R.J., Pfeiffer R.F., Trenkwalder C., Homann N., Ott E., Wenzel K., Asmus F., Hardy J., Wszolek Z., and Gasser T. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am. J. Hum. Genet. 74 (2004) 11-19